Cargando…

Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study

BACKGROUND: Antituberculosis-drug resistance is an important public health issue, and its epidemiological patterns has dramatically changed in recent decades. This study aimed to estimate the trends of multidrug-resistant tuberculosis (MDR-TB), which can be used to inform health strategies. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Ze-Jin, Yu, Dan-Feng, Liang, Yuan-Hao, He, Wen-Qiao, Li, Yong-Zhi, Meng, Ya-Xian, Xiong, Hu-Sheng, Zhang, Min-Yi, He, Huan, Gao, Yu-Han, Wu, Fei, Chen, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936417/
https://www.ncbi.nlm.nih.gov/pubmed/33676581
http://dx.doi.org/10.1186/s40249-021-00803-w
_version_ 1783661187826712576
author Ou, Ze-Jin
Yu, Dan-Feng
Liang, Yuan-Hao
He, Wen-Qiao
Li, Yong-Zhi
Meng, Ya-Xian
Xiong, Hu-Sheng
Zhang, Min-Yi
He, Huan
Gao, Yu-Han
Wu, Fei
Chen, Qing
author_facet Ou, Ze-Jin
Yu, Dan-Feng
Liang, Yuan-Hao
He, Wen-Qiao
Li, Yong-Zhi
Meng, Ya-Xian
Xiong, Hu-Sheng
Zhang, Min-Yi
He, Huan
Gao, Yu-Han
Wu, Fei
Chen, Qing
author_sort Ou, Ze-Jin
collection PubMed
description BACKGROUND: Antituberculosis-drug resistance is an important public health issue, and its epidemiological patterns has dramatically changed in recent decades. This study aimed to estimate the trends of multidrug-resistant tuberculosis (MDR-TB), which can be used to inform health strategies. METHODS: Data were collected from the Global Burden of Disease study 2017. The estimated annual percentage changes (EAPCs) were calculated to assess the trends of MDR-TB burden at global, regional, and national level from 1990 to 2017 using the linear regression model. RESULTS: Globally, the age-standardized rate (ASR) of MDR-TB burden including incidence, prevalence, death and disability-adjusted life years (DALYs) had pronounced increasing trends from 1990 to 1999, with the EAPCs were 17.63 [95% confidence interval (CI): 10.77–24.92], 17.57 (95% CI 11.51–23.95), 21.21 (95% CI 15.96–26.69), and 21.90 (95% CI 16.55–27.50), respectively. Particularly, the largest increasing trends were seen in areas and countries with low and low-middle sociodemographic index (SDI). However, the trends in incidence, prevalence, death and DALYs of MDR-TB decreased globally from 2000 to 2017, with the respective EAPCs were − 1.37 (95% CI − 1.62 to − 1.12), − 1.32 (95% CI − 1.38 to − 1.26), − 3.30 (95% CI − 3.56 to − 3.04) and − 3.32 (95% CI − 3.59 to − 3.06). Decreasing trends of MDR-TB were observed in most regions and countries, particularly that of death and DALYs in Slovenia were − 18.96 (95% CI − 20.82 to − 17.06) and -19.35 (95% CI − 21.10 to − 17.55), respectively. Whereas the pronounced increasing trends of MDR-TB occurred in Papua New Guinea, Singapore, and Australia. CONCLUSIONS: The ASR of MDR-TB showed pronounced decreasing trends from 2000 to 2017. However, the MDR-TB burden remains a substantial challenge to the TB control globally, and requires effective control strategies and healthcare systems. [Image: see text]
format Online
Article
Text
id pubmed-7936417
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79364172021-03-08 Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study Ou, Ze-Jin Yu, Dan-Feng Liang, Yuan-Hao He, Wen-Qiao Li, Yong-Zhi Meng, Ya-Xian Xiong, Hu-Sheng Zhang, Min-Yi He, Huan Gao, Yu-Han Wu, Fei Chen, Qing Infect Dis Poverty Research Article BACKGROUND: Antituberculosis-drug resistance is an important public health issue, and its epidemiological patterns has dramatically changed in recent decades. This study aimed to estimate the trends of multidrug-resistant tuberculosis (MDR-TB), which can be used to inform health strategies. METHODS: Data were collected from the Global Burden of Disease study 2017. The estimated annual percentage changes (EAPCs) were calculated to assess the trends of MDR-TB burden at global, regional, and national level from 1990 to 2017 using the linear regression model. RESULTS: Globally, the age-standardized rate (ASR) of MDR-TB burden including incidence, prevalence, death and disability-adjusted life years (DALYs) had pronounced increasing trends from 1990 to 1999, with the EAPCs were 17.63 [95% confidence interval (CI): 10.77–24.92], 17.57 (95% CI 11.51–23.95), 21.21 (95% CI 15.96–26.69), and 21.90 (95% CI 16.55–27.50), respectively. Particularly, the largest increasing trends were seen in areas and countries with low and low-middle sociodemographic index (SDI). However, the trends in incidence, prevalence, death and DALYs of MDR-TB decreased globally from 2000 to 2017, with the respective EAPCs were − 1.37 (95% CI − 1.62 to − 1.12), − 1.32 (95% CI − 1.38 to − 1.26), − 3.30 (95% CI − 3.56 to − 3.04) and − 3.32 (95% CI − 3.59 to − 3.06). Decreasing trends of MDR-TB were observed in most regions and countries, particularly that of death and DALYs in Slovenia were − 18.96 (95% CI − 20.82 to − 17.06) and -19.35 (95% CI − 21.10 to − 17.55), respectively. Whereas the pronounced increasing trends of MDR-TB occurred in Papua New Guinea, Singapore, and Australia. CONCLUSIONS: The ASR of MDR-TB showed pronounced decreasing trends from 2000 to 2017. However, the MDR-TB burden remains a substantial challenge to the TB control globally, and requires effective control strategies and healthcare systems. [Image: see text] BioMed Central 2021-03-06 /pmc/articles/PMC7936417/ /pubmed/33676581 http://dx.doi.org/10.1186/s40249-021-00803-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Ou, Ze-Jin
Yu, Dan-Feng
Liang, Yuan-Hao
He, Wen-Qiao
Li, Yong-Zhi
Meng, Ya-Xian
Xiong, Hu-Sheng
Zhang, Min-Yi
He, Huan
Gao, Yu-Han
Wu, Fei
Chen, Qing
Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study
title Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study
title_full Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study
title_fullStr Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study
title_full_unstemmed Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study
title_short Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study
title_sort trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the global burden of disease study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936417/
https://www.ncbi.nlm.nih.gov/pubmed/33676581
http://dx.doi.org/10.1186/s40249-021-00803-w
work_keys_str_mv AT ouzejin trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT yudanfeng trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT liangyuanhao trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT hewenqiao trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT liyongzhi trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT mengyaxian trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT xionghusheng trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT zhangminyi trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT hehuan trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT gaoyuhan trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT wufei trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy
AT chenqing trendsinburdenofmultidrugresistanttuberculosisincountriesregionsandworldwidefrom1990to2017resultsfromtheglobalburdenofdiseasestudy